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Background: Aortic clamping during abdominal aortic aneurysm repair 
surgery leads to complications such as systemic inflammatory response (SIRS) 
and dysfunction in various vital organs. This study aimed to investigate the 
effect of dexmedetomidine infusion on transcription factors and inflammatory 
cytokines during elective open abdominal aortic aneurysm repair surgery.  
Materials and Methods: A prospective, clinical trial performed on patients 
with abdominal aortic aneurysm surgery, which were divided into two groups 
(dexmedetomidine, 8 patients and control, 12 patients). Demographic 
characteristics, biochemical laboratory variables, fluid and blood transfusions 
during surgery, and levels of inflammatory cytokines and expression of 
inflammatory genes were evaluated and compared in both groups.  
Results: There were no significant differences between the two groups 
regarding demographic characteristics, biochemical laboratory variables, 
fluids, and blood transfusions during surgery (P> 0.05). The level of 
inflammatory cytokines and the expression of inflammatory genes in both 
groups decreased significantly after surgery (P <0.05). However, the level of 
inflammatory cytokines and the expression of inflammatory genes in the 
dexmedetomidine group were significantly lower at the end of the surgery (P 
<0.05).  
Conclusion: In abdominal aortic aneurysm surgery, dexmedetomidine could 
significantly reduce complications of clamping during surgery, which may 
result in hemodynamic stability and prevent significant inflammatory 
response to surgical stress and organ damage following ischemia-reperfusion 
damage.  
Keywords: Abdominal aortic aneurysm, Inflammatory factors, Transcription 
factors, Blood transfusion, Hemodynamics, Clamping, Declamping 
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Introduction 
The average prevalence of a ruptured abdominal aortic 
aneurysm (AAA or triple-A) is 5.6-17.5 per 100,000 
people, and the mortality rate is about 80-90% (1-4). 
Despite advances in surgical procedures and 
preoperative care, AAAR is often associated with high 
mortality (5). 
One of the most common complications leading 
to death during AAAR is acute organ injury following 
the intraoperative blood flow cessation due to aortic 
clamping (6). Clamping during AAAR leads to 
complications such as SIRS, dysfunction of various 
organs, which can even lead to death (7-9). 
Aortic clamping leads to the release of 
catecholamines, followed by an increase in systemic 
vasospasm, resulting in arterial stenosis and a decrease 
in venous capacity (10). Following a rapid decrease in 
blood flow, oxygen decreases in the tissues distal to the 
aortic clamping, and oxygen uptake increases in the 
organs proximal to the clamp. Also, clamping leads to 
a disrupted cellular metabolism due to increased levels 
of inflammatory molecules, oxygen-free radicals, and 
the complement system (11). 
Declamping is also associated with 
complications. The first hemodynamic response to 
declamping is a significant reduction in blood pressure, 
hypoxia-induced vasodilation of peripheral arteries, 
and excessive secretion of vasodilator metabolites 
from tissues distal to the clamp. Following clamping 
and blood flow retention, various inflammatory 
pathways are activated. Reperfusion leads to the 
production of oxygen-free radicals, activation of the 
complement system, and white blood cells, and platelet 
aggregation (12-19). Researchers attribute the 
inflammatory process in patients undergoing AAAR to 
several biochemical factors. Previous studies have 
shown that hypoxia-inducible factor-1A (HIF-1A) 
plays a key role in initiating inflammatory processes. 
Extracellular adenosine has been identified as 
a key factor in controlling the inflammation caused 
by hypoxic and ischemic lesions (20). 
Serum interleukin-1 (IL-1) and IL-6 levels have 
been shown to increase during AAAR and in the 
postoperative period. Increased serum tumor necrosis 
factor-α (TNF-α) levels during surgery are also 
associated with further postoperative complications 
(21-23). 
Activation of T cells is controlled by a group of 
transcription factors such as Runx1 and Runx3, which 
are directly affected by the expression of T-bet, 
GATA-3, and RORγt gene (24, 25). The balance or 
imbalance between T helper1 / T helper 2 as well as T-
helper1 / regulatory T cells plays an important role in 
many pathological processes such as surgical stress or 
ischemic-reperfusion processes and inflammatory 
responses can be measured by expression of T-bet, 
GATA-3, RORγt, and Foxp3 genes (26, 27). 
Dexmedetomidine, a highly selective alpha-2 
adrenergic agonist, is widely administrated as a 
premedication to induce anesthesia. Laboratory studies 
have shown that it has a preventive effect on the release 
of inflammatory cytokines and apoptosis (23, 28, 29). 
The present study investigated the role of 
dexmedetomidine in AAAR on the serum levels of IL-
1, IL-6, and TNF-α and expression of mRNAs related 
to systemic inflammation, and the production of 
cytokines such as GATA-3, T-bet, ROR𝛾-T, and 
Foxp3. 
There is limited information in the literature on 
the effects of dexmedetomidine on the level of the 
inflammatory cytokine, followed by AAAR. 
Considering the effect of the answer to this question on 
the postoperative prognosis and outcome, this study is 
one of the research priorities. 
Methods 
The present clinical trial was performed on patients 
undergoing elective open AAAR at Shohada-e Tajrish 
Hospital in Tehran between October 2017 and October 
2019. AAAR patients entered the study after approval 
of the project and its methodology by the Iranian 
Registry of Clinical Trails (IRCT20190121042444N1) 
and the ethics committee of Shahid Beheshti 
University of Medical Sciences 
(IR.SBMU.RETECH.REC.1397.348) and obtaining 
permissions from the head of the Department of 
Anesthesiology of Shohada-e Tajrish Hospital.  
Exclusion criteria include the previous history 
of aortic surgery, inflammatory bowel disease (IBD), 
malignancies, chronic inflammatory diseases, 
corticosteroid use, emergency surgery, and any patient 
instability during surgery. Before the start of the study, 
a researcher interviewed patients to describe the study, 
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the aim of the project, and the possible side effects of 
the project. Patients who signed the written consent 
were included in the study. After selecting eligible 
patients, they were randomly divided into control 
(n=12) and experimental groups (dexmedetomidine 
infusion) (n= 8). 
Intraoperative care included invasive blood 
pressure monitoring, central venous pressure 
measurement, pulse oximetry, electrocardiography, 
and bispectral index (BIS). For induction of anesthesia 
in all patients, midazolam (0.01 mg/Kg), fentanyl 
(0.2mcg/Kg), lidocaine (1.5 mg / Kg), etomidate (0.2 
mg/Kg), and cisatracurium (0.2 mg/Kg) were 
administrated, respectively. We used sevoflurane 1% 
for anesthesia maintenance and cisatracurium, and 
fentanyl was administrated every 45 minutes. After 
intubation, the CV line and arterial line were inserted 
for all patients, and surgery was started after 
completion of monitoring. In the experimental group, 
dexmedetomidine infusion was started immediately 
after intravenous injection of anesthetic (0.5 µg / Kg / 
h) and discontinued upon clamping. 
Patient information such as the duration of the 
surgery, the duration of the aortic clamping, the 
amount of blood loss, the required intraoperative 
packed cell and FFP units, and the surgical 
complications, along with other demographic 
information prepared by the researchers, were recorded 
in questionnaires. 
To measure serum IL-1, IL-6, and TNF-α levels 
and their gene expression and Foxp3, GATA3, 
RORγT, and T-bet expression once after induction of 
anesthesia before incision (baseline) and once 24 hours 
after completion of the surgery, blood samples were 
obtained through the patient's central venous catheter 
and collected in tubes containing 
ethylenediaminetetraacetic acid (EDTA). The blood 
samples were then placed in a centrifuge (2000 rpm) 
for 10 minutes; the sample plasma was removed from 
the surface, collected in glass tubes, and stored in a 
freezer at -80 °C until biochemical tests. The samples 
were then heated to reach a temperature of 4°C for 
biochemical evaluation. The level of inflammatory 
cytokines and the mRNAs expression were measured 
using laboratory kits. 
The normal distribution of quantitative 
variables was investigated using the Kolmogorov-
Smirnov test and box and normal probability plots. To 
compare the quantitative variables between the two 
groups, Student’s t-test, and if necessary, the Mann–
Whitney U test was used. Chi-square test was used to 
compare qualitative variables between the two groups 
and if necessary, Fisher's exact was done. A One-way 
ANOVA test was used to compare the normality 
between the three groups and the Kruskal–Wallis test 
was used in the case of non-normal data distribution. 
P-value< 5% was considered significant in all two-
tailed statistical tests. Data analysis was carried out 
 
Figure 1. IL-1 level before and after surgery in control and experimental group. 
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using SPSS version 21; (version 11.5; SPSS Inc, 
Chicago, IL, USA). 
 
Results 
Demographic characteristics had no significant 
differences between the two groups (Table 1). The 
same was true regarding admission-related variables 
(Table 2). Systolic and diastolic blood pressure were 
higher in the dexmedetomidine group than the control 
group after clamping, being at times statistically 
significant. Besides, the mean central venous pressure 
(CVP) was generally higher in the dexmedetomidine 
group than the control group at all measured times, and 
this difference was sometimes statistically significant. 
It should be noted that dexmedetomidine infusion was 
stopped after clamping. 
Tables 2 and 3, show the levels of expressed 
genes of inflammatory cytokines and compare their 
levels before and after surgery in each group alone, as 
 
Figure 2. IL-6 level before and after surgery in control and experimental group. 
 
 
Figure 3. TNF-α level before and after surgery in control and experimental group. 
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well as the expression levels of these genes between 
control and dexmedetomidine groups after surgery, 
respectively. 
As shown in Table 3, there is a significant 
increase in IL-1, IL-6, and interferon-alpha (IFN-α) 
levels in the control group, as well as the expression of 
GATA3 and RORγ-T genes in the postoperative 
period, compared to the preoperative time (P<0.05). In 
contrast, such a significant increase in the 
inflammatory cytokines and T-bet gene expression was 
observed in the postoperative phase as compared to the 
preoperative phase (P<0.05). 
 
Discussion 
The present study aimed to investigate the effect of 
dexmedetomidine on the expression of inflammatory 
genes in patients undergoing elective open AAAR. 
 
Figure 4. GATA-3 level before and after surgery in control and experimental group. 
 
Figure 5. RORγ-T level before and after surgery in control and experimental group. 
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Overall, the results showed that the expression of 
inflammatory cytokine genes and transcription factors 
were significantly reduced in all patients except 
mRNA T-bet after surgery in the dexmedetomidine 
group.  
Studies have shown that aortic clamping causes 
the release of catecholamines during AAAR, followed 
by an increase in systemic vasospasm, resulting in 
arterial stenosis and a decrease in venous capacity (10). 
This rapid decrease in blood flow leads to an increase 
in the rate of anaerobic metabolic reactions, lactic 
acidosis, and also, decreased glycogen, increased 
inflammatory molecules levels, oxygen-free radicals, 
and disorders of the complement system. (7, 11)  
On the other hand, clamping significantly 
reduces blood pressure and causes hypoxia-induced 
vasodilation of peripheral arteries and the excessive 
secretion of vasodilator metabolites from tissues distal 
to the clamping site. On the other hand, following the 
clamping and blood flow retention, various 
inflammatory pathways are activated and biochemical 
changes happen, and reestablishing oxygen flow 
causes ischemia-reperfusion injury. These results in 
the formation of oxygen-free radicals, the activation of 
 
Figure 6. Foxp3 level before and after surgery in control and experimental group. 
 
Figure 7. T-bet level before and after surgery in control and experimental group. 
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the complement system, platelet aggregation, and the 
activation of white blood cells, leading to 
microvascular dysfunction in the tissues and organs 
distal to the clamping site (12-19).  
Dexmedetomidine is a highly selective alpha-2 
adrenergic agonist with a sedative and analgesic effect 
and is administrated as a sedative and short-term sleep-
inducing drug in the clinic (30). Although many studies 
Table 1: Comparison of demographic characteristics of patients in control and experimental group. 
Variable Control Group Experimental Group P-value 
Age 69.83±10.8 75.75±7.1 0.10 
Gender Male 10 5 0.29 
Female 2 3 
Blood Group A+ 4 1 0.302 
AB+ 1 0 
B+ 3 3 
O- 2 0 
O+ 2 4 
Diabetes mellitus 2 2 0.53 
Hypertension 10 8 0.34 
History of Cardiac Disease 10 8 0.34 
 
Table 2: Comparison of Biochemical variables, crystalloid and blood products of two groups during surgery. 
Variable Control Group Experimental Group P-value 
Hemoglobin 12.52±1.3 12.54±1.6 0.97 
Platelet 174.58±74.9 195.00±84.3 0.62 
Blood Sugar 102.0±15.7 106.00±18.0 0.49 
INR 1.15±0.1 1.03±0.0 0.06 
Duration of Surgery (Hour) 3.97±0.4 3.86±0.4 0.48 
Urine Output (cc) 700 ±286.6 1061.25±520.7 0.11 
Normal Saline (L) 3.4±0.3 3.5±0.3 0.51 
Ringer Lactate (L) 0.92±1.3 0.19±0.5 0.02 
Length of ICU Stay 2.33±0.8 1.88±0.8 0.27 
Length of Hospital Stay 2.33±0.6 3.25±1.1 0.06 
Packed Red Blood Cell 1 1 0 0.34 
2 0 2 
3 1 0 
4 1 1 
Plasma 1 2 4 0.10 
2 4 4 
3 2 0 
Days till expiration of Packed Red Blood Cell 9.75±7.9 16.00±4.0 0.06 
 
Behnaz et al.                                               Effect of Dexmedetomidine on Transcription Factors and Inflammatory Cytokines… 
Journal of Cellular & Molecular Anesthesia (JCMA) 
138 
have been performed on the effect of dexmedetomidine 
in various surgeries, there has been still no study on its 
effect on vascular surgery, including AAAR and its 
effects on controlling inflammatory reactions 
following clamping and declamping. One of the 
reasons for the absence of studies on the effect of 
dexmedetomidine in this surgery is hypotension and 
hemodynamic instability during surgery. Therefore, 
hemodynamic stability was maintained through 
continuous monitoring of patients, and the patient was 
excluded in the case of hemodynamic instability. 
The importance of this issue is that in addition 
to the need to maintain the patient's hemodynamic 
stability during AAR, and avoid unwanted 
hypotension, the clamps increase the complications of 
ischemic-reperfusion injury (IRI) in patients. 
The results of the present study showed that the 
intraoperative dexmedetomidine administration, 
clamping, and declamping maintained the 
hemodynamic stability of patients and prevented 
severe intraoperative hypotension in patients compared 
to the control group. 
Previous studies have proved the effect of 
dexmedetomidine on the hemodynamic system. 
Dexmedetomidine causes temporary vasoconstriction, 
followed by an increase in mean arterial blood 
pressure, and physiologically a decrease in heart rate 
by stimulating alpha-2 receptors on vascular smooth 
muscles. In addition to its effects on peripheral arteries, 
dexmedetomidine induces a sedative effect by 
affecting the central nervous system, decreases the 
number of circulating catecholamines which cause; 
these effects suppress the surgical stress and minimize 
hemodynamic fluctuations (31, 32). 
In a study, Jalkanen et al. (2016) measured the 
severity of the response to systemic inflammation in 
patients undergoing open AAAR by measuring 
inflammatory factors. To investigate the serum level of 
inflammatory factors in their study, blood samples 
were taken from 6 patients undergoing aortic clamping 
in AAAR and 6 patients undergoing joint femoral 
surgery before and 24 hours after surgery. In this study, 
Table 3: Comparison of expression of inflammatory cytokines Before and after surgery in both groups. 
 Variable Before Surgery After Surgery P-Value 
Control mRNA IL-1 0.22±0.4 0.20±0.03 0.002* 
mRNA IL-6 1.89±0.09 1.84±0.08 0.002* 
mRNA TNF-α 15.51±0.08 15.32±0.15 0.002* 
mRNA GATA-3 18.12±3.2 20.99±5.35 0.002* 
mRNA RORγ-T 18.28±3.3 23.40±3.3 0.028* 
mRNA Foxp3 16.25±1.6 17.81±4.6 0.09 
mRNA T-bet 17.39±2.9 19.30±1.6 0.05 
Experimental mRNA IL-1 0.22±0.2 0.15±0.02 0.011* 
mRNA IL-6 1.91±0.03 1.46±0.07 0.012* 
mRNA TNF-α 15.48±0.22 13.10±0.13 0.012* 
mRNA GATA-3 15.43±2.2 16.38±1.15 0.205 
mRNA RORγ-T 18.01±3.9 18.06±1.02 0.67 
mRNA Foxp3 13.92±2.3 14.28±2.17 0.15 
mRNA T-bet 14.12±0.6 19.62±1.92 0.01* 
 
Table 4: Comparison of studied gene expression after surgery in both groups. 
Variable Control Group Experimental Group P-value 
mRNA IL-1 0.20±0.03 0.15±0.02 0.007* 
mRNA IL-6 1.84±0.08 1.46±0.07 <0.001* 
mRNA TNF-α 15.32±0.15 13.10±0.13 <0.001* 
mRNA GATA-3 20.99±5.35 16.38±1.15 0.022* 
mRNA RORγ-T 23.40±3.3 18.06±1.02 0.004* 
mRNA Foxp3 17.81±4.6 14.28±2.17 0.033* 
mRNA T-bet 19.30±1.6 19.62±1.92 0.064 
 
Effect of Dexmedetomidine on Transcription Factors and Inflammatory Cytokines ….                                       Behnaz et al. 
Vol 5, No 3, Summer 2020 
139 
48 different types of cytokines were evaluated in blood 
samples. The results of this study showed the highest 
increase in Il-6 and growth hormone after surgery (P = 
0.016). HIF-1 levels also increased significantly in all 
patients except patients who had undergone blood 
transfusion during surgery. On the other hand, despite 
the significant increase in HIF-1 level after clamping, 
the CD39 and CD73 levels were significantly reduced. 
Jalkanen et al. concluded that aortic clamping induced 
a strong systemic inflammatory response and that 
appropriate drug therapy strategies should be used to 
reduce the complications of postoperative systemic 
inflammation (33). 
In another study on the pattern of inflammatory 
cytokines levels before and after AAAR, Otterhag et 
al. (2014) investigated inflammatory mediators such as 
soluble urokinase-type plasminogen activator receptor 
(suPAR), endothelin, TNF-α, Il-6, and IgM antibodies 
against phosphorylcholine in 21 patients undergoing 
AAAR before and after surgery. The found that the 
serum suPAR, endothelin, and IL-6 levels were 
significantly increased after surgery. In contrast, IgM 
antibodies against phosphorylcholine levels were 
significantly reduced. The results of this study 
indicated that AAAR is associated with increased 
serum levels of inflammatory biomarkers, which may 
be affected by reconstructive surgery. It was also stated 
in this study that the serum IL-6 level can be used as 
one of the predictors of short-term surgical 
complications in patients living with aortic aneurysms 
(34).  
Talke et al. (1995) conducted the first study on 
the role of dexmedetomidine in vascular surgery. In 
this study, they assessed the dose-dependent 
hemodynamic effects associated with 
dexmedetomidine infusion with different targeted 
plasma concentrations before the surgery in at-risk 
coronary artery disease patients. They concluded that 
dexmedetomidine reduced heart rate and systolic blood 
pressure in a dose-dependent manner (35). In a 
subsequent study on the effect of dexmedetomidine on 
the adrenergic and hemodynamic systems of patients 
undergoing vascular surgery, Talke et al. showed that 
dexmedetomidine infusion reduced the rate of increase 
in heart rate and plasma norepinephrine when 
anesthetizing patients undergoing vascular surgery 
(32). 
In two meta-analyses on the effect of 
dexmedetomidine on vascular surgery, Vigisundra et 
al. showed that α-2 -adrenergic agonists reduced 
overall mortality, mortality from cardiac disease, and 
myocardial infarction during major vascular surgeries. 
These Meta-analyses reviewed 23 studies (n=3395 
patients) and 31 studies (n=4578 patients) in 2003 and 
2009, respectively (36, 37). 
Soleyman & Zahri found fewer cases of 
hypertension and hypotension, lower demands for 
antihypertensive drugs in the aortic closure phase, as 
well as vasopressors in the declamping phase, and 
crystalloids, sevoflurane, and fentanyl in 
dexmedetomidine recipient patients undergoing 
AAAR. However, the most interesting finding of this 
study was the cardioprotective effect of 
dexmedetomidine, as evidenced by decreased 
postoperative plasma concentrations of troponin I, 
fewer cases of ischemia and myocardial infarction, and 
fewer cases of rhythm disturbances on 
echocardiography (38). 
In another study on patients undergoing 
vascular surgery, Nair et al. showed that 
dexmedetomidine maintained hemodynamic stability 
during induction, surgery, and extubation in patients 
undergoing carotid endarterectomy (39). Bekker et al. 
also found that dexmedetomidine significantly reduced 
the need for beta-blockers and antihypertensive drugs 
and minimized hemodynamic fluctuations in awake 
patients undergoing carotid endarterectomy (40). 
In recent years, many studies have investigated 
inflammatory activities induced by environmental 
stresses such as surgery and its effect on the body's 
inflammatory activity and the cells responsible for 
these processes. These studies have shown that the 
activity of T cells as one of the most important cells 
involved in inflammatory processes is controlled by a 
group of transcription factors such as Runx1 and 
Runx3, which are themselves directly affected by the 
T-bet gene, GATA-3, and RORγts expression (24, 25). 
Regulatory T cells (Tregs), on the other hand, play an 
important role in immune tolerance and stability, 
which is controlled by the Foxp3 transcription factor. 
Balance or imbalance between T helper 1 and 2 as well 
as T helper 1 and Tregs has been shown to play an 
important role in many pathological processes (such as 
stress caused by surgery or ischemic-reperfusion 
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processes). The inflammatory response to different 
stresses can be easily measured by measuring the 
expression of T-bet, GATA-3, RORγt, and Foxp3 
genes (instead of measuring the amount of each cell 
alone) (26, 27). 
Results of the present study showed that 
dexmedetomidine was effective in reducing the 
expression of genes involved in inflammatory 
activities of T cells. As explained, the decrease in the 
expression of the genes measured in the present study 
indicates a decrease in inflammatory cell 
differentiation and thus modulation of inflammatory 
processes, which leads to a decrease in the production 
of inflammatory cytokines such as IL- 1, IL- 6, and 
IFN-α. The importance of reduced T cell inflammatory 
activity during surgery is that inflammatory activity 
modulation occurring following the ischemic-
reperfusion process during surgical procedures that 
require clamping and declamping processes can lead to 
a reduction in reactive oxygen species (ROS) 
production and subsequent cell survival (41). 
Consistent with the results of the present study, 
two clinical trials have shown that intraoperative 
dexmedetomidine administration can inhibit the 
ischemic-reperfusion-induced inflammatory response 
during cardiopulmonary bypass. The first trial was 
carried out on patients undergoing coronary artery 
bypass grafting (CABG) or valve replacement surgery, 
and dexmedetomidine was administered as a bolus (1 
μg/kg) within 10 minutes, followed by 0.5 μg / kg 
infusion per hour. In this study, the inflammatory 
response was measured using plasma concentrations of 
high-mobility group box protein (HMGB) and IL-6 as 
well as activation of nuclear factor KB (NF-κB) in 
neutrophils (42). In the second trial, CABG patients 
were examined who underwent partial 
cardiopulmonary bypass and dexmedetomidine (0.3 μg 
/ kg / h) was started before the induction of anesthesia 
without loading doses. In this second trial, IL-1 and IL-
6, TNF-α, and INF-γ were measured as indicators of 
the inflammatory response (43). As mentioned above, 
the results of the two clinical trials confirmed the 
significant reduction in inflammatory factors in the 
dexmedetomidine group as compared with the control 
group, which are consistent with the results of the 
present study suggesting the effective role of this drug 
in controlling inflammatory activities in vascular 
surgery requiring clamping and declamping. 
Basic science studies have been performed to 
justify the anti-inflammatory effects of 
dexmedetomidine, and the results showed that 
dexmedetomidine prevents apoptosis of 
cardiomyocytes following IRI by inhibiting 
endoplasmic reticulum stress and reducing the 
production of reactive oxygen species (ROS) (44). In 
the central nervous system, dexmedetomidine can 
activate HIF-1α and suppress neuronal autophagy after 
cerebral ischemia (45). At the same time, 
dexmedetomidine inhibits activation of Toll-Like 
Receptor 4 (TLR4) and NF-κB pathways and 
microglia, leading to neuroprotection and the 
protection of neurons against inflammatory injury (46). 
The beneficial effect of dexmedetomidine on renal 
tissue has also been observed. dexmedetomidine 
treatment reduces neuroinflammation and oxidative 
stress following ischemic-reperfusion and increases 
renal cell survival by activating the extracellular-
signal-regulated kinases (ERK) and Protein kinase B 
(PKB, also known as Akt) signaling pathways (41, 47). 
It has also been reported that dexmedetomidine 
activates phosphoinositide 3-kinases (PI3K), AKT, 
and HIF-1α pathways following IRI in the lung tissue, 
thus stimulating angiogenesis, maintaining glucose- 
metabolism, and ultimately facilitating ischemic 
preconditioning and cell survival (48). 
Dexmedetomidine also has antioxidant and anti-
inflammatory effects, which have a protective effect 
against surgical stress by inhibiting the production of 
pro-inflammatory cytokines and lipid peroxidation (8, 
49, 50). Clinical evidence suggests that 
dexmedetomidine-induced sedation suppresses the 
inflammatory response caused by TNF-α, IL-1b, and 
IL-6 (51, 52). Animal studies have also shown that 
dexmedetomidine is effective in inhibiting the release 
of cytokines during inflammatory responses and thus 
reducing mortality, and in protecting organs and tissues 
considering its anti-inflammatory properties (53, 54). 
Conclusion 
Overall, the results of clinical and laboratory studies 
have shown that intraoperative dexmedetomidine 
administration in patients undergoing AAAR can 
significantly reduce complications caused by 
clamping-declamping processes, which can lead to 
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impaired hemodynamic stability as well as IRI. 
However, further studies with higher sample size and 
measurement of other inflammatory and anti-
inflammatory factors are recommended. 
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